Report cover image

Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

Publisher Kalorama Information
Published May 19, 2020
Length 124 Pages
SKU # KLI16241993

Description

Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets.

Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood cell count (RBC).

Kalorama’s examination of the global market for hematology testing includes analyzers/instruments and reagents: all commercial laboratory and hospital-based products, some research use products used in clinical laboratories, and OTC product sales (not test services). Market data points presented include:
  • Global Hematology Testing Market by Product Segment, 2019-2024 ($ million) (Laboratory-based Hematology, Decentralized [POC] Hematology, Hematology Testing Market)
  • Global Laboratory-based Hematology Test and Instrument Market, 2019 and 2024 ($ millions)
  • Global Laboratory-based Hematology Test and Instrument Market, by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
  • Top Tier Hematology, Company Revenues (Laboratory and POC), 2019 ($ millions)
  • Decentralized Hematology Test and Instrument Market, 2019 and 2024 ($ millions)
  • Global Decentralized Hematology Test and Instrument Market, by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
  • Hematology Analyzer Distribution of Sales by Menu Capability, 2019 estimated (%) (5-part diff analyzer sales, 3-part diff analyzer sales, Other analyzers)
  • Lab-based Hematology Sales by Analyte, 2019 estimated (%) (CBC, Hemoglobin, Other specialized)
Hemostasis (coagulation) is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis and platelet aggregation are a part of this process. Hemostasis testing needs vary from laboratory to laboratory, with some facilities only performing routine pre-operative testing (PT/INR and PTT), while others also conduct specialty testing (coagulation factors). In either scenario, steadily increasing patient testing volumes, coupled with growing demand to produce reliable results quickly, have required laboratories to seek hemostasis testing solutions that enhance efficiency by providing consistent results and streamline workflow.

Kalorama’s evaluation of the global market for coagulation tests (lab-based and all POC) includes d-dimer as a segment in the market. Market data points presented:
  • Global Coagulation Diagnostic Markets by Segment, 2019-2024 ($ millions) (PT/INR - Lab, D-dimer - Lab, Molecular - Lab, Professional POC, Self POC)
  • Global D-dimer Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
  • Global Coagulation Test and Instrument Market by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
  • Top Coagulation (Laboratory-based and POC) Company Revenues, 2019 ($ millions)
The report contains some discussion of COVID-19 as it relates to the hematology and coagulation markets. Several global health organizations and health professionals have reported negative effects of COVID-19 in patients with hematological diseases, including rare diseases such as sickle cell disease and thalassemia. Coagulation testing, including d-dimer, is considered to be a growing indicator of the impact and clinical outcomes of patients with COVID-19. Several international organizations are leading the charge in identifying and publishing recommendations and guidances for coagulopathy management in COVID-19 patients.

Hematology and Coagulation Markets (Lab-based and Decentralized Markets) concludes with company profiles and review:
  • Abbott Diagnostics
    • Beckman Coulter, Inc. / Danaher
    • CellaVision AB
    • Diagnostica Stago, S.A.S.
    • DIAGON Kft. Hungary
    • HemoCue / Radiometer / Danaher
    • Horiba Medical
    • Medica Corporation
    • Microvisk Technologies
    • Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
    • Roche Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Werfen (Instrumentation Laboratory, Accriva Diagnostics)
    • West Medica

    • *Note: The full report pricing option allows for 1-10 users in a single department*

    Table of Contents

    124 Pages
      • Hematology Overview
      • Hematology Market Overview
      • Coagulation Overview
      • Coagulation Market Overview
      • Scope and Methodology
      • COVID-19 and Hematology / Coagulation
      • Introduction
      • Digital Image Analysis
      • Quality Control Measurement Programs
      • Overview
      • Product Overview
      • Market Summary
      • Overview
      • Hemoglobin/Hematocrit at the POC
      • Market Summary
      • Summary
      • The Commercial Outlook for Hematology Tests
      • Special Topics
      • Market Analysis
      • Lab-based Testing
      • Decentralized Coagulation Testing – Professional Use
      • Leading Suppliers
      • The Commercial Market for Coagulation Tests
      • Abbott Diagnostics
      • Beckman Coulter, Inc. / Danaher
      • CellaVision AB
      • Diagnostica Stago, S.A.S.
      • DIAGON Kft. Hungary
      • HemoCue / Radiometer / Danaher
      • Horiba Medical
      • Medica Corporation
      • Microvisk Technologies
      • Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
      • Roche Diagnostics
      • Siemens Healthineers
      • Sysmex Corporation
      • Werfen (Instrumentation Laboratory, Accriva Diagnostics)
      • West Medica

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us